A detailed history of Sterling Capital Management LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 3,844 shares of VNDA stock, worth $16,721. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,844
Previous 1,528 151.57%
Holding current value
$16,721
Previous $7.21 Million 165.97%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$4.19 - $5.1 $9,704 - $11,811
2,316 Added 151.57%
3,844 $19.2 Million
Q2 2025

Aug 06, 2025

BUY
$3.92 - $4.82 $2,132 - $2,622
544 Added 55.28%
1,528 $7.21 Million
Q1 2025

May 13, 2025

SELL
$4.31 - $5.13 $3,633 - $4,324
-843 Reduced 46.14%
984 $4.52 Million
Q4 2024

Feb 13, 2025

BUY
$4.41 - $5.46 $7,258 - $8,987
1,646 Added 909.39%
1,827 $8.75 Million
Q3 2024

Nov 12, 2024

BUY
$4.61 - $6.34 $834 - $1,147
181 New
181 $849,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $246M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.